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ABSTRACT: The fates of RNA species in a cell are controlled by ribonucleases, which degrade them by exploiting the universal
structural 2′-OH group. This phenomenon plays a key role in numerous transformative technologies, for example, RNA interference
and CRISPR/Cas13-based RNA editing systems. These approaches, however, are genetic or oligomer-based and so have inherent
limitations. This has led to interest in the development of small molecules capable of degrading nucleic acids in a targeted manner.
Here we describe click-degraders, small molecules that can be covalently attached to RNA species through click-chemistry and can
degrade them, that are akin to ribonucleases. By using these molecules, we have developed the meCLICK-Seq (methylation CLICK-
degradation Sequencing) a method to identify RNA modification substrates with high resolution at intronic and intergenic regions.
The method hijacks RNA methyltransferase activity to introduce an alkyne, instead of a methyl, moiety on RNA. Subsequent
copper(I)-catalyzed azide−alkyne cycloaddition reaction with the click-degrader leads to RNA cleavage and degradation exploiting a
mechanism used by endogenous ribonucleases. Focusing on N6-methyladenosine (m6A), meCLICK-Seq identifies methylated
transcripts, determines RNA methylase specificity, and reliably maps modification sites in intronic and intergenic regions.
Importantly, we show that METTL16 deposits m6A to intronic polyadenylation (IPA) sites, which suggests a potential role for
METTL16 in IPA and, in turn, splicing. Unlike other methods, the readout of meCLICK-Seq is depletion, not enrichment, of
modified RNA species, which allows a comprehensive and dynamic study of RNA modifications throughout the transcriptome,
including regions of low abundance. The click-degraders are highly modular and so may be exploited to study any RNA modification
and design new technologies that rely on RNA degradation.
Targeted cutting and degradation of RNA plays key rolesin a wide array of cellular mechanisms, such as RNA
turnover,1,2 processing,3 and innate immune responses.4 These
mechanisms are harnessed in technologies, such as RNA
interference5 and CRISPR/Cas13 systems.6 However, these
platforms are genetically encoded or oligomer-based, which
limits their applicability. Small molecules that target and
degrade RNA circumvent many of these limitations and
expand the scope for RNA degradation approaches.7,8 So far,
their availability is limited and their platforms lack the
modularity of genetically encoded approaches. Thus, a strategy
that retains the modularity and scope of small-molecule
targeting of RNA is highly desirable.
We have come up with a concept of click-degraders, small
molecules that can be covalently attached to any RNA species
by click chemistry, degrading them in a similar way to
ribonucleases. To demonstrate the power of this concept, we
have developed meCLICK-Seq (methylation−CLICK-degra-
dation sequencing), a small-molecule-based transcriptome-
editing platform that hijacks endogenous RNA methylation
pathways9 to induce specific cleavage and degradation of
methylated RNAs (Figure 1a), and used it to carry out a
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transcriptome-wide sequencing of methylated RNA writer
substrates to determine the specificity of m6A writer enzymes.
What makes meCLICK-Seq unique among RNA modification
sequencing methods is that its readout is depletion, not
enrichment, of methylated RNA species, which allows reliable
high-throughput sequencing in a wider range of RNA species
than before. meCLICK-Seq has numerous other advantages
over other available RNA sequencing methods. Unlike
Figure 1. meCLICK-Seq, a small molecule-based methylated RNA editing platform. (a) Proposed mechanism of action of meCLICK-Seq. (b)
Conversion of PropSeMet into SeAdoYn and subsequent introduction of propargyl groups into RNA. (c) Functionalization of propargylated RNA
with the click-degrader. (d) Proposed mechanism of the general base RNA degradation. (e) Copper-mediated RNA degradation.
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antibody-based methods,2,10−12 meCLICK-Seq does not
require large quantities of RNA (so is ideal for large parallel
studies and for use with rare cellular populations), does not
rely on availability of an antibody against a particular
modification and is catalytically dependent, and so captures a
dynamic picture of RNA modifications at a given time. Unlike
antibody-free RNA methylation mapping methods,13−15
meCLICK-Seq does not involve enzymatic or any other kind
of RNA processing besides the regular sequencing pipelines.
RNA degradation is achieved by direct treatment of cultured
cells with small molecules; this avoids enzymatic biases.
Importantly, the meCLICK-Seq platform is highly modular,
and the click-degrader can be used with different probes to
map different RNA modifications, for example, acetylation or
isopentenylation, and with suitable cellular models, the
approach described here can be used to study any type of
RNA methylation.
Despite the complex mechanism, meCLICK-Seq involves
just two cell culture treatment steps. In the first step, cells are
incubated with methionine surrogate PropSeMet (PSM) after
30 min of methionine starvation. Cells take up the methionine
surrogate, and native methionine adenosyltransferases trans-
form it into SeAdoYn, an S-adenosyl methionine (SAM)
surrogate. RNA methyltransferases (MTases), including
METTL3 and METTL16, use SeAdoYn as a cofactor, instead
of SAM, which leads to the addition of propargyl, instead of
methyl, groups onto RNA (Figure 1b).16 A Cu(I)-catalyzed
azide−alkyne cycloaddition (CuAAC) reaction is then carried
out directly on cultured cells to tag RNA with a click-degrader,
which acts as a functional artificial RNA modification that
catalyzes the cleavage of RNA and leads to its degradation
(Figure 1c). This in situ step prevents further RNA processing
and minimizes treatment biases. The imidazole-based click-
degrader has a dual mechanism. It acts as a general base that
abstracts a proton from the 2′-O position on RNA that leads to
cleavage, similarly to ribonucleases and other artificial nuclease
mimics (Figure 1d).17−19 It also cleaves RNA in a copper-
dependent manner, which mimics several nucleic acid-cleaving
natural products (Figure 1e20). As a result, this cleavage leads
to decreased levels of methylated substrates, which can be
directly quantified to provide information about the methyl-
ation status of any RNA transcript in real time.
■ RESULTS AND DISCUSSION
Click-Degraders Function through a Dual Chemical
Mechanism. To demonstrate the validity of our RNA
degradation strategy and to probe the chemical mechanism
of click-degraders, we have carried out in vitro experiments on
a synthetic RNA 11-mer functionalized with a propargyl
moiety on one of its 6A positions. An unmodified 11-mer was
used as a control. We went on to attach the click-degrader onto
alkynylated RNA so as to observe what effect it has on RNA
stability. Under optimal conditions, CuAAC RNA functional-
ization was complete in approximately 10 min (Figure S1a−c).
Furthermore, we found that upon incubation at 37 °C, the
functionalized RNA gets gradually degraded (Figure 2a).
Figure 2. Study of the chemical mechanism of click-degraders. (a) Time-dependent degradation of click-degrader 1 functionalized RNA 11-mer at
37 °C. n = 2. (b) Extent of RNA degradation after 14 h at 37 °C, pH 7.5, n = 2. (c) Extent of RNA degradation after 14 h at 37 °C, pH 3.0, n = 2.
(d) Extent of RNA degradation in neutral and acidic conditions, n = 2. (e) Extent of RNA degradation after 14 h at 37 °C, pH 7.5, with PEG linkers
of differing lengths. Cinitial corresponds to initial concentration; C corresponds to concentration at a specified time point. Click-degraders 1, 2, and 3
have linkers with 6, 4, and 2 PEG subunits, respectively, n = 2. Error bars represent SD.
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Figure 3. meCLICK-Seq elucidates the relationship between m6A writers and methylation of mRNAs and lncRNAs. (a) meCLICK-Seq workflow.
(b) Western blots demonstrate the extent of METTL3 and METTL16 depletion in conditional knock-down MOLM-13 cells treated with
PropSeMet. Application of click-degrader does not significantly alter the levels of MTases. (c) Heat map showing decrease of methylated mRNA
levels upon clicking and rescue of METTL3-dependent transcripts upon METTL3 depletion. (d) Overlap of m6A-containing mRNAs determined
through m6A miCLIP and METTL3 mRNA substrates determined by meCLICK-Seq; significance indicated by Fisher’s exact test. (e) RT-qPCR-
based meCLICK-Seq validation of a panel of genes, n = 3. (f) RT-qPCR-based meCLICK-Seq validation of a panel of genes in METTL3 depleted
cells, n = 3. (g) Genome browser snapshot of NEAT1. Applying click machinery diminishes the WT but not METTL3 or METTL16 levels. p values
determined with one-tailed t test. ns = not significant (p ≥ 0.05). Error bars represent SD.
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Although the kinetic profile of RNA degradation may be
complex, first-order half-lives are often used as an estimate of
RNA stability.21 By using a first-order approximation, we have
calculated the functionalized RNA 11-mer to have a half-life of
2.6 h (Figure S1d). Additionally, we carried out the click-
degrader functionalization and degradation on two longer
oligomers (Figure S2a−c). In both cases, longer oligomers got
degraded more extensively than the 11-mer (Figure S1e). This
might be because longer oligomers have more sites susceptible
to degradation. We have also compared the effects of click-
chemistry components (copper sulfate, THPTA, sodium
ascorbate, and the click-degrader) on alkynylated and non-
alkynylated control oligomer. Only 9% of the alkynylated click-
degrader-functionalized RNA remained after 14 h of
incubation, whereas almost no degradation was observed
when an identical click-degrader treatment was applied to a
control RNA oligomer that lacks the propargyl handle and the
ability to be click-functionalized (Figure 2b). To obtain further
evidence that the click-components only affect the stability of
functionalized RNA, we have carried out the click-functional-
ization and degradation on a mixture of control and
propargylated 11-mers (both at 100 μM). Again, extensive
degradation was observed exclusively for the click-degrader
functionalized oligomer (Figure S1f,g). These results demon-
strate that only the covalently imidazole-functionalized RNA is
degraded, so the observed effect is specific to modified RNA
and not the result of nonspecific degradation, for example from
the click-degrader, copper, and ascorbate.
To gain insight into the mechanism of click-degraders, we
carried out in vitro degradation reactions under conditions that
suppress certain mechanisms. To investigate whether copper
plays a role, we ran reactions quenched with either the copper
chelator bathocuproinedisulfonic acid (BCS) or the general
metal chelator ethylenediaminetetraacetic acid (EDTA). In the
presence of these chelators, 68% and 79% of RNA remained
intact, respectively (Figure 2b), which suggests that copper
plays a key role in the degradation process. To investigate the
role of our click-degrader as a general base, we carried out the
reaction under acidic conditions (pH 3), in which imidazole on
the click-degrader is protonated and nonbasic but intrinsic
RNA stability is comparable to neutral conditions,22 as well as
under basic conditions (pH 8.5), in which the imidazole is
nearly completely deprotonated. In the case of pH 3.0, 15% of
functionalized RNA was retained, which is almost twice as
much as under pH 7.5, whereas the nonpropargylated oligomer
was not significantly affected; at pH 8.5 only 2% of
functionalized RNA remained intact (Figures 2c,d and S1h).
Similar trends were observed when the functionalized 11-mer
was degraded at pH 3.0, 7.5, and 8.5 for 2 h (Figure S1i).
Importantly, no significant RNA degradation was observed in
the presence of BCS at pH 3 when both copper and general
base mechanisms are blocked (Figure 2c). These findings show
that both copper-dependent and general base mechanisms are
relevant and sufficient to explain the chemical mechanism of
our click-degrader. We were also interested whether other
transition metals as well as noncoordinated copper in tandem
with the click-degrader are able to facilitate degradation. To
look into this, we used the minimum amount of copper−
THPTA complex (100 μM) for the CuAAC reaction, followed
by quenching of copper with BCS (200 μM) and the addition
of other transition metals (1 mM of corresponding chloride).
Interestingly, we found that Zn(II) facilitates the degradation
but Fe(II) does not (Figure S1j). This result suggests that in
the cellular environment, cofactors other than copper can
facilitate the degradation of functionalized RNAs. In addition,
we also investigated how the length of the click-degrader linker
affects the efficiency of degradation. We tested three different
linker lengths [6, 4, and 2 poly(ethylene glycol) (PEG)
subunits] and found that the longest linker led to the most
efficient degradation, possibly because it is more flexible and
provides a better reach for imidazole (Figure 2e). It was
difficult to isolate and test click-degraders with even longer
linkers, so we used click-degrader 1 (6 PEG subunits) for
downstream experiments.
To gain further insight into the mechanism of the click-
degrader, we have carried out liquid chromatography−mass
spectrometry (MS) and RNA gel analyses on the degradation
products of the click-degrader functionalized 11-mer. The MS
analysis was carried out on LCMS traces of degraded RNA
products of the functionalized 11-mer. In all the degraded
samples many peaks corresponding to different masses were
observed, suggesting that the degradation results in the
formation of many different RNA products (Figure S3a−c,
Supporting Table S1). An RNA degradation reaction
quenched with BCS also revealed formation of numerous
RNA products, however there was a different pattern of
observed peaks, suggesting that the click-degrader can cleave
RNA on many different sites through the general base
mechanism (Figure S3d, Supporting Table S2). The RNA
gels were in agreement with LCMS results: formation of a
smear was observed upon prolonged degradation, further
suggesting formation of multiple RNA species (Figure S3e,f).
Altogether, these results have implications for detection of 2′-
O-methylated RNA species (e.g., m6Am). As the degradation
can take place on many different positions, the 2′-O-Me should
not protect RNA from degradation (with potential exceptions
where several such modifications are nested together); thus
meCLICK-Seq should be adaptable for detection of
modifications such as m6Am.
Elucidation of mRNA Substrates of m6A Writers.
Upregulation of RNA methylation was shown to play a pivotal
role in the maintenance of cancers, including acute myeloid
leukemia (AML) cells.23,24 We thus went on to investigate
whether PropSeMet treatment results in formation of
propargyl groups on a human acute myeloid leukemia cell
line, MOLM13, as well as a kidney cancer cell line, HEK293T,
focusing on the propargyl version (Pr6A) of the RNA
modification m6A, the most abundant type of mRNA
methylation. Indeed, having analyzed via mass spectrometry
the RNA of these cells after PropSeMet treatment, we
observed formation of the propargylated adenosine on
polyA-enriched RNA (Figure S4a,b). Having demonstrated
that PropSeMet is a probe capable of inducing RNA
propargylation, we went on to apply meCLICK-Seq to the
human AML cell line MOLM-13 (Figure 3a). We used
isogenic MOLM-13 cells stably transduced with conditional
shRNAs against METTL3 or METTL16, both known to be
m6A writers,25,26 or scrambled shRNA as control (Figure
3b).27 As our platform is catalysis-dependent, the loss or down-
regulation of an RNA methyltransferase is predicted to
eliminate degradation of its RNA substrates. Initially, we
observed that the abundance of many mRNAs was reduced in
clicked but not control (PropSeMet-fed but not clicked) cells,
which suggests successful intracellular degradation of methy-
lated transcripts (Figure 3c and Figure S5a). Strikingly, levels
of many of these transcripts were restored in cells with either
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Figure 4. meCLICK-Seq reveals widespread m6A mark in introns and intergenic regions. (a) Intronic peaks in the first intron of FLI1. (b) Intronic
peaks in the first intron of CADM1 in three isogenic cell models. Intronic peaks are abolished specifically in METTL16-KD cells. (c) Overlap
between METTL3- and METTL16-dependent intronic peaks. (d) Distribution of METTL3-dependent peaks in intronic and intergenic regions.
(e) Distribution of METTL16-dependent peaks in intronic and intergenic regions. (f) RT-qPCR-based validation of a panel intronic peaks, n = 3.
(g) Validation of dependence of intronic peaks on RNA methylases METTL3 and METTL16, n = 3. (h) Results of m6A-RIP in cells with
methylated introns removed by dual gRNA system, n = 3. (i) Results of m6A-RIP in cells with depleted METTL3, n = 3. (j) Results of m6A-RIP in
cells with depleted METTL16. RASA3 peak 2 is not affected by the knock-down illustrating that the observed effect is enzyme-specific, n = 3. ns =
not significant (p ≥ 0.05). Error bars represent SD.
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METTL3 or METT16 downregulation, which suggests that
methylation of the relevant RNAs was mediated by the
catalytic activity of the corresponding MTase. In particular, we
identified 5441 METTL3- and 7656 METTL16-dependent
mRNA substrates (Supporting Table S3). We then cross-
compared our findings to results of an m6A individual-
nucleotide resolution cross-linking and immunoprecipitation
(miCLIP)12 sequencing experiment carried out on MOLM-13
cells (Supporting Table S4).28 We observed a consistent
overlap for both enzymes with 69% of METTL3 and 67% of
METTL16 mRNA substrates identified through meCLICK-
Seq reported to contain m6A sites by miCLIP (Figure 3d and
Figure S5b). Furthermore, we found that the m6A methylation
of 5159 mRNAs depends on both MTases and that the
majority of the identified methylated substrates are dependent
on METTL16, which is in line with the fact that METTL16 is
the modulator of cellular cofactor SAM and its levels (Figure
S5c).25,29 It is thus likely that many of the overlapping
substrates are methylated predominantly by METTL3, whose
catalytic activity in part depends on METTL16. In a similar
fashion, METTL16- but not METTL3-dependent m6A-
containing substrates are most likely directly methylated by
METTL16. To check whether these results can be observed by
independent methods, we used RT-qPCR to validate a panel of
m6A-containing transcripts (Figure 3e,f and Figure S5d).
Notably, this validation mirrored the results of the RNA-seq
highlighting the specificity of our platform. Furthermore, to
show that the click components, on their own, have little effect
on the individual transcript levels, we carried out qPCR on a
panel of m6A substrates using RNA extracted from starved
MOLM13 cells treated with the same click conditions as
PropSeMet-fed cells. We observed no significant differences in
substrate abundances between treated and nontreated cells,
showing that the observed effects result from the click-degrader
functionalization and not the individual click components
(Figure S5e). Thus, we have demonstrated that meCLICK-Seq
can specifically identify the mRNA substrates of RNA MTases
and the results agree closely with the results of antibody-based
approaches.
Many lncRNAs Are METTL3 or METTL16 Substrates.
Another group of RNAs reported to be heavily methylated are
long noncoding RNAs (lncRNAs). We therefore investigated
whether our meCLICK-Seq platform could identify methyl-
ation changes on this RNA subgroup focusing again on
METTL3- and METTL16-dependent m6A events.30 For
example, NEAT1 was shown to be a target of m6A demethylase
ALKBH5, although the MTases that deposit the modifications
were not identified.31 Through meCLICK-Seq, we demon-
strate that the methylation of NEAT1 depends on both
METTL3 and METTL16 (Figure 3g). In total, we identified
689 METTL3-dependent and 889 METTL16-dependent
lncRNAs, out of which 77 and 104, respectively, significantly
overlapped with lncRNA substrates shown to contain m6A sites
by miCLIP sequencing (Figure S5f,g and Supporting Table
S5). Interestingly, we observed that the overlap between
meCLICK-Seq and m6A miCLIP, albeit significant, is much
smaller for lncRNAs than for mRNAs. Furthermore,
meCLICK-Seq was able to identify a greater number of
lncRNA substrates than m6A miCLIP, the opposite to what
was observed for mRNAs, which suggests that our platform
efficiently probes lncRNA methylation without antibody
biases. Similar to mRNAs, the majority of lncRNAs are
promiscuous m6A substrates because methylation of 562
lncRNAs (56% of total identified) appeared to be dependent
on both METTL3 and METTL16 (Figure S5h). We were also
able to validate a number of these findings by RT-qPCR
(Figure S5i). Furthermore, to investigate whether meCLICK-
Seq is able to degrade and therefore identify RNA species that
contain methylation on known secondary structures, we
validated using qPCR the lncRNA MALAT1 with primers
designed to target the m6A-containing loop (Figure S6a).32 We
observed extensive degradation, showing that our method
could indeed target methylation on secondary structures.
Overall, using meCLICK-Seq, we have thus revealed m6A
methylation on lncRNAs in a MTase-dependent fashion.
To provide additional evidence that PropSeMet treatment
does indeed result in formation of propargylated adenosine
(Pr6A) on natively m6A-containing species and to show that
CuAAC click reaction can effectively take place on these sites,
we carried out a biotin−streptavidin pull-down experiment.
Briefly, we treated MOLM13 cells with PropSeMet and reacted
the propargylated RNA with biotin-azide probe, followed by
streptavidin pull-down and qPCR analysis of a panel of known
m6A-containing species. As expected, these RNA species were
successfully enriched after full PropSeMet−biotin treatment
but not in any of the controls that omit one of the
components, indicating that these RNA species were indeed
labeled with PropSeMet as well as providing an additional
method to validate sufficiently abundant methylated RNA
species (Figure S6b). Altogether, these experiments provide
further evidence that PropSeMet treatment indeed results in
propargylation of mRNA.
meCLICK-Seq Reveals That m6A Is Widespread in
Intronic and Intergenic Regions. Rather unexpectedly,
further interrogation of our RNAseq data with the meCLICK-
Seq platform revealed high-resolution peaks in intronic and
intergenic regions. The majority of these peaks were highly
sensitive to functionalization with the click-degrader, which
indicates that these regions were indeed modified by MTases
(Figure 4a). These peaks might be a result of the artificial
propargyl modification interfering with RNA recycling path-
ways and perhaps leading to increased stability. Another
interesting observation was the pronounced loss of abundance
of many identified peaks in cells depleted of either METTL3 or
METTL16, which implies that these MTases regulate
methylation at the corresponding peaks (Figure 4b and Figure
S7a−d). In total, we have found 1345 METTL3- and 9618
METTL16-dependent intronic and intergenic peaks that lost
abundance upon clicking and hence had the modification
(Figure 4c) with the distribution of these peaks appearing
different for the two MTases (Supporting Table S6). In line
with recent literature,23,33,34 50% of METTL3-dependent
peaks were found in intergenic regions (relative to 23% for
METTL16) further highlighting the involvement of METTL3
in chromatin associated or cotranscriptional pathways (Figure
4d,e). Moreover, more than 77% of METTL16-dependent
peaks were located in intronic regions with 36% of those found
in the first intron, unexpected for a 3′-biased method. This
highlights the different roles these MTases play in mRNA
modification, with METTL16 regulating the modification in
many more intronic regions than METTL3. This is in line with
previous reports about the cotranscriptional role of METTL3
and METTL16 in depositing m6A in introns.25,35 meCLICK-
Seq is thus the first method to capture widespread methylation
in low-abundance transcriptomic regions at such high
resolution and low RNA input. Unlike antibody-based intronic
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analysis, meCLICK-Seq does not require enrichment of
nascent RNA to observe intronic methylation.
To further demonstrate that the peaks we found contain
bona f ide m6A sites, we performed motif analysis. We find that
variations of the DRACH and TACAG motifs, the respective
consensus sequences for METTL3 and METTL16, are
dramatically overrepresented in METTL3- and METTL16-
dependent peaks, respectively (Figure S8a,b).29,36,37 We also
compared the overlap between these peaks and m6A sites
found in introns and exons by m6A miCLIP. A significant
overlap was observed for both METTL3- and METTL16-
dependent peaks, which provides further evidence that the
observed peaks have m6A sites (Figure S8c,d). Furthermore, a
centered distribution of distances between miCLIP sites and
meCLICK-Seq peaks was observed (Figure S8e,f). We also
validated some of these peaks by RT-qPCR. The results
echoed the findings of RNA-seq (Figure 4f). Furthermore, we
observed a decrease in the intensity of meCLICK-Seq peaks in
the click group, identical to the results obtained by RNA-Seq
(Figure 4g). To validate the intronic results with additional,
independent methods, we derived cell lines with deletions in
intronic regions that correspond to METTL3- or METTL16-
dependent meCLICK-Seq peaks. This was done by using
CRISPR-Cas9, with dual gRNAs targeting the flanks of
selected meCLICK-Seq peaks. Using m6A-RIP-qPCR, we
found that cells with introns removed via CRISPR had
significantly less m6A compared to cells containing empty
CRISPR-Cas9 vectors (Figure 4h). Additionally, in MOLM-13
cells with either METTL3 or METTL16 knock-down, the
m6A-RIP signal was selectively decreased at peaks dependent
on the relevant RNA MTase, further validating the results of
meCLICK-Seq (Figure 4i,j). Combined, this shows that the
meCLICK-Seq peaks contain m6A sites and hold information
about MTase specificity.
meCLICK-Seq Can Determine Substrates for Other
RNA Methylations. Through further interrogation of
meCLICK-Seq data sets we demonstrated that the method
can be used for study of different types of methylation. For this
aim, we compared our findings with a published data set for 7-
methyl guanosine (m7G), obtained through m7G-Seq.38 We
found a significant overlap between modified mRNAs
determined by the two methods, with 378 overlapping genes
(Figure S9a and Supporting Table S7). Strikingly, 82 click-
sensitive intronic and intergenic peaks were found to be in
vicinity of m7G-Seq-determined sites, a number significantly
higher than expected from a random distribution (Figure S9b,c
and Supporting Table S8). Thus, meCLICK-Seq is able to
probe various types of RNA methylation.
METTL16 Is Linked to Intronic Polyadenylation Sites.
To better understand the presence of intronic peaks in our
analysis, we decided to investigate the connection to intronic
polyadenylation (IPA) given the fact that we used polyA-
enriched RNA for RNA-seq analysis. IPA has been recently
reported to be widespread in cancers and to inactivate certain
tumor suppressors in leukemia.39,40 To determine whether IPA
is associated with the presence of m6A, we compared the
positions of meCLICK-Seq peaks to IPA sites of leukemia cells
identified in a published study by 3′-Seq.39 For additional
confidence, we applied very strict parameters and only
considered meCLICK-Seq peaks positioned on the exact IPA
site. Strikingly, significant overlap was found between
METTL16- but not METTL3-dependent peaks and the IPA
sites (Figure S10a,b and Supporting Table S4). Moreover, the
distribution of METTL16 peaks around the IPA sites
suggested a link between the two, with a large number of
the peaks overlapping or being close to the IPA sites (Figure
S10c). These data suggest that METTL16 has a possible role
in IPA and, in turn, splicing, and also demonstrate that
meCLICK-Seq can be used to interrogate methylation of low-
abundance transcripts.
■ CONCLUSIONS
We have designed click-degraders, small molecules that are
clicked onto RNA to induce its degradation, and by using them
we developed meCLICK-Seq, a powerful small-molecule-based
method for the study of diverse aspects of cellular RNA
methylation, including high-confidence mapping of methyl-
ation in low abundance transcripts transcribed from introns
and intergenic regions. Unlike many RNA methylation
sequencing methods, meCLICK-Seq is unbiased and depends
strictly on the catalytic activity of RNA MTases, such that it
can determine their transcript and locus specificity. The
method offers the reproducibility characteristics of small-
molecule-based methods, is easy to perform, and has low RNA
input requirements, which make it ideal for parallel character-
ization of different cell types, rare purified populations, and
tissues. meCLICK-Seq is perhaps the first non-microscopic
method to apply click chemistry directly on cells with a
quantifiable output. Antibody-based methods provide a biased
picture of methylation at any given time, whereas meCLICK-
Seq reports a dynamic state of methylation in a cell. Unlike
most antibody-free RNA methylation mapping methods,
meCLICK-Seq does not involve complex postextraction
RNA modification or processing. Furthermore, this is one of
the first studies that exploit functional artificial RNA
modifications for a measurable biological output.
We used meCLICK-Seq to define the transcript substrates of
m6A writers METTL3 and METTL16 and their overlap. We
have also demonstrated that m6A is widespread in lncRNAs
and intronic and intergenic regions, where it is deposited
primarily by METTL16. Furthermore, we demonstrate for the
first time the prevalence of m6A modification in polyadenylated
introns, which have been shown to be oncogenic contributions
in cancer.39,40
meCLICK-Seq is highly modular, and by use of suitable
models and metabolic labeling it can be adapted to study of
other RNA methyltransferases and demethylases as well as
other RNA modifications. With a modified workflow this
method could also be adapted to investigate and characterize
DNA modifications. The majority of studies of RNA
methylation focus on high-abundance RNA species, whereas
the role of methylation in low-abundance species is largely
uncharacterized owing to a lack of molecular tools. We foresee
meCLICK-Seq enabling the study of RNA modifications in
previously inaccessible regions of the transcriptome. Defects in
intron-related mechanisms are implicated in a wide range of
pathologies,41 and much remains to be learned about the role
of noncoding RNAs in disease.42 We expect that our click-
degradation platform will facilitate both fundamental and
translational discoveries about the role of RNA modifications
throughout the transcriptome and, in parallel, pave the way for
the development of new technologies aimed to expand the
capabilities of targeted nucleic acid degradation.
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■ EXPERIMENTAL SECTION
In Vitro Click-Degrader Functionalization Reactions.
In a standard reaction, CuSO4 (final concentration 1.0 mM),
tris(3-hydroxypropyltriazolylmethyl)amine (THPTA, 3.0
mM), click-degrader (2.0 mM), and the RNA oligomer (200
μM) were added to pH 7.5 or pH 3 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES, 20 mM) or pH 8.5
TRIS (100 mM) buffer supplemented with 10 mM MgCl2 and
100 mM KCl. CuAAC was initiated by adding sodium
ascorbate (NaAsc, 50 mM). The reaction mixture was then
incubated at 37 °C. Reactions to generate calibration curves
were quenched with EDTA (12 mM) 20 min after adding
NaAsc to allow complete functionalization of the RNA
oligomer. Reactions involving prequenching were quenched
with EDTA (12 mM) or bathocuproinedisulfonic acid (BCS, 3
mM) 20 min after adding NaAsc. After quenching, the reaction
mixtures were analyzed using LCMS. For all samples, an initial
concentration was calculated from analysis of an appropriate
oligomer treated under click conditions for 20 min, ensuring
full functionalization of propargylated oligomers. Identities of
RNA species present were determined by their mass (Figure
S6−S10). For nonstandard reactions, the conditions are
specified in the text.
LCMS Analysis of Oligonucleotides. Oligomers were
analyzed using a Xevo G2-S TOF mass spectrometer coupled
to an Acquity UPLC system using an Acquity UPLC BEH C18
1.7 μm column. The system utilizes electrospray ionization
(ESI). Two mobile phases were used, 16.3 mM TEA, 400 mM
HFIP in H2O and 16.3 mM TEA, 400 mM HFIP in 80:20 v/v
MeCN and H2O, with a flow rate of 0.200 mL/min.
Calibration curves for the RNA species were based either on
A260 or intensities of specified negative m/z signals (Figure
S1e−h). Intensities of integrated peaks were calculated using
native modules of KNIME software platform.43 Total mass
spectra were reconstructed from the ion series using the
MaxEnt algorithm preinstalled on MassLynx software (v. 4.1
from Waters) according to the manufacturer’s instructions. To
obtain the negative ion series described, the oligomer peak in
the chromatogram was selected for integration and further
analysis.
RNA Degradation Gel Electrophoresis. In vitro RNA
degradation reactions were carried out as described above. The
quenched reaction mixture was mixed in 1:1 ratio with a
loading buffer (95% formamide, 0.025% SDS, 0.025%
bromophenol blue (BPB), 0.025% xylene cyanol FF, 0.025%
ethidium bromide, 0.5 mM EDTA), heated at 70 °C for 5 min,
and cooled to 0 °C. PAGE was performed on NovexTM TBE-
Urea Gels, containing 15% polyacrylamide under 1× TBE
buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA) at 180 V
for 60 min. Gel staining was performed using SYBR Green II
RNA Gel Stain (Invitrogen) in 1× TBE buffer. The stained
RNA was visualized with ChemiDoc MP (Bio-Rad, United
Kingdom).
Cell Culture. MOLM13 cells were cultured in RPMI1640
(Gibco) supplemented with 10% v/v FBS and 1% v/v
penicillin/streptomycin/L-glutamine. 293T cells were cultured
in DMEM (Gibco) supplemented with 10% v/v FBS and 1%
v/v penicillin/streptomycin/L-glutamine.
Lentiviral Vector Production, Infection, and Trans-
fection. For virus production, 293T cells were transfected
with lentiviral vector pLKO.1 together with the packaging
plasmids PAX2 and VSVg at a 1:1.5:0.5 ratio. Supernatant was
harvested 48 and 72 h after transfection. Cells (1 × 106) and
viral supernatant were mixed in 2 mL of culture medium
supplemented with 8 μg mL−1 Polybrene (Millipore), followed
by spinfection (60 min, 900g, 32 °C), and further incubated
overnight at 37 °C. The medium was refreshed on the
following day, and the transduced cells were further cultured.
Generation of Conditional Knock-down and Intronic
Deletion-Containing Cells. MOLM-13 cells were trans-
fected using Lipofectamine 2000 reagent (Invitrogen)
according to the manufacturer’s instructions using pLKO-
TETon-Puro lentiviral vectors expressing shRNAs against the
coding sequence of human METTL3, METTL16, or a
scrambled control. Twenty-four hours after spinfection, the
cells were replated in fresh medium containing 1 μg mL−1 of
puromycin and kept in selection medium for 7 days. Anti-
METTL3 and scrambled shRNAs were induced by treating the
cells with 200 ng mL−1 tetracycline for 3 days, anti-METTL16
was induced by identical treatment for 2 days.
gRNA assays were performed using dual gRNA vectors as
reported previously.44 Viral supernatants were collected 48 h
after transfection. All transfections and viral collections were
performed in 15 cm plates as mentioned below. For virus
production, 5 μg of the above plasmids and 5 μg of psi-Eco
packaging vector were transfected dropwise into the 293T cells
using 47.5 μL TransIT LT1 (Mirus) and 600 μL of Opti-MEM
(Invitrogen). The resulting viral supernatant was harvested,
and transduction of cells was performed in 6-well plates. After
transduction, transduced cells were sorted for BFP (for
gRNA). The gRNA sequences are listed in Table S12.
Cellular RNA Degradation Reactions (meCLICK-Seq).
MOLM13 cells were suspended in methionine-free RPMI-
1640 media (Gibco) supplemented with 10% v/v FBS and 1%
v/v penicillin/streptomycin/L-glutamine at a density of
1 000 000 cells mL−1. The cells were incubated for 30 min at
37 °C followed by addition of PropSeMet at a final
concentration of 150 μM. Treated cells were incubated for
further 16 h at 37 °C. Aqueous solutions of premixed CuSO4
and THPTA were added at final concentrations of 100 and 300
μM, respectively, followed by the click-degrader 1 at 400 μM
and NaAsc at 5 mM. Treated cells were incubated for 10 min
at 37 °C and resuspended in complete RPMI-1640 medium.
Afterward, the cells were again incubated at 37 °C and
harvested after 5 h for RNA extraction.
m6A RNA Immunoprecipitation. Total RNA was isolated
from MOLM-13 control, Δintronic, METTL3-KD, or
METTL16-KD cells (two independent biological replicates
for each shRNA) 8 days after doxycycline administration using
the RNAeasy midi kit (Qiagen). Successively polyA enriched
RNA was purified from 300 μg of total RNA using the
NEBNext Poly(A) mRNA Magnetic Isolation Module (New
England Biolabs). For each immunoprecipitation reaction, 500
ng of polyA+ purified RNA was used. m6A RNA
immunoprecipitation was performed using the Magna MeRIP
m6A kit (Millipore) according to the manufacturer’s
instructions. Immunoprecipitated RNA was analyzed via RT-
qPCR.
RNA Extraction, Reverse Transcription, and RT-qPCR.
Total RNA was extracted from pelleted cells using RNAeasy
Mini Kit (Qiagen) according to the manufacturer’s instruc-
tions. Twenty micrograms of total RNA was enriched for
polyA-containing sequences using Dynabeads mRNA purifica-
tion kit (Invitrogen) according to the manufacturer’s
instructions. One microgram of total RNA and all of the
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polyA-enriched RNA from the previous step were retrotran-
scribed using SuperScript Vilo Master Mix (Invitrogen)
according the to manufacturer’s instructions. Levels of specific
RNAs were measured using fast mode of StepOnePlus Real-
Time PCR System (Applied Biosystems) and Fast SYBR
Green Master Mix (Applied Biosystems) according to the
manufacturer’s instructions. For reactions where total RNA
was used, RNA levels were normalized to 18S subunit of the
ribosome. For reactions where polyA-enriched RNA was used,
RNA levels were normalized to RPL32 mRNA. These
housekeeping genes were chosen as their levels fluctuated
the least under various conditions tested. Primer sequences are
listed below.
Statistical Analysis. General statistical analyses were
carried out using a one-sided (in cases where we were
interested only in a decrease of signal in the treated group) or
two-sided Student’s t test at a confidence interval of 95%.
Protein Extraction and Immunoblotting. The cells
were lysed in whole-cell lysis buffer (50 mM Tris-HCl, pH 8,
150 mM NaCl, 0.1% NP-40, and 1 mM EDTA) supplemented
with 1 mM DTT, protease inhibitors (Sigma), and
phosphatase inhibitors (Sigma). Protein quantities were
estimated with Bradford assays (Bio-Rad). The protein
samples were supplemented with SDS−PAGE sample buffer,
and DTT was added to each sample. Protein (10−40 μg) was
separated on a 4−12% Bis-Tris SDS−PAGE gel (Invitrogen)
with a same amount of protein added to each track of a gel and
blotted onto poly(vinylidene difluoride) membranes (Milli-
pore). Visualization was performed using LumiGLO Chem-
iluminescent Substrate (KPL, 54-61-00) and X-ray film (GE
Healthcare). The following antibodies were used: anti-
METTL3 from Bethyl Laboratories (A301-568A), anti-
METTL16 from Abcam (ab185990), anti-β-actin from
Abcam (ab8227), goat anti-rabbit IgG H&L (HRP) from
Abcam (ab205718).
HPLC-MS/MS Analysis of RNA. Up to 10 μg of poly(A)
RNA was decapped with Cap-Clip Acid Pyrophosphatase
(Cellscript) for 90 min at 37 °C, then digested with 100 U of
P1 nuclease (New England Biolabs) at 37 °C overnight and
dephosphorylated with 1 U of rSAP (New England Biolabs) at
37 °C for 1 h. The 100 μL samples were filtered with Millex-
GV 0.22 μm filters (Millipore Sigma). Five to ten microliters
from each sample was injected into the Agilent 6470 Triple
Quad LC/MS instrument with Agilent Zorbax Eclipse C18
reverse phase HPLC column. The samples were run at 500
μL/min flow rate in mobile phase buffer A (water with 0.1%
formic acid) and 0−20% gradient of buffer B (methanol with
0.1% formic Acid). MRM transitions were measured for
adenosine (268.1 to 136.1), guanosine (284.1 to 152.1), and
Pr6A (306.1 to 174.1). Standard compound for Pr6A was run
on HLPC-MS/MS to optimize the HPLC method and
determine retention times. For LC-MS/MS data collection
and analysis, Agilent Mass Hunter LC/MS Data Acquisition,
version B.08.00, and Quantitative Analysis, version B.07.01,
software were used.
Biotin Pull-down Experiment. RNA was extracted from
PropSeMet treated MOLM13 cells as described above.
CuAAC reaction was then performed in 20 mM HEPES
(pH 7.5) on 7 μg of RNA, 20 μM azide-PEG3−biotin
conjugate (Sigma-Aldrich), 5 mM CuSO4, 15 mM THPTA,
and 5 mM NaAsc, to a final volume of 100 μL. After initiating
the reaction with NaAsc, the mixture was stirred at 37 °C for
30 min, followed by quenching of the reaction with 6 mM
EDTA. Biotinylated RNA was then precipitated with EtOH
and redissolved in 30 μL of nuclease-free water. Streptavidin
pull-down was carried out using streptavidin beads (Invi-
trogen) according to the manufacturer’s instructions. RNA was
then analyzed via RT-qPCR as described above with
abundance of each transcript in the pulled-down RNA
compared to corresponding input RNA.
Bioinformatic Analysis. Total RNA was extracted from
pelleted cells using RNAeasy Mini Kit (Qiagen) according to
the manufacturer’s instructions. RNaseq data from all experi-
ments consisting of 75 bp paired-end Illumina reads were
mapped to the human genome assembly GRCh38 by STAR
2.7.1b,45 using arguments “--outSAMunmapped Within Keep-
Pairs --outFilterIntronMotifs RemoveNoncanonicalUnanno-
tated --chimSegmentMin 0 --chimJunctionOverhangMin 20”.
BigWig files were produced by deepTools 3.3.246 bamCover-
age using RPKM normalization. Exonic reads were removed
using the intersect function in Bedtools, v2.29.0,47 and exon
regions derived from the Ensembl GRCh38, version 93. Reads
on the forward strand were extracted using Samtools 1.9,48
with “view -f 128 -F 16” and “-f 80” and merged into one file.
Reads on the reverse strand were extracted using “view -f 144”
and “-f 64 -F 16” and merged. Broad peaks were called by
MACS2 2.1.4,49 using WT as treatment and METTL16/
METTL3 as control, with arguments “callpeak --broad --extsize
= 300 --keep-dup 20 --nomodel -g hs --broad-cutoff 0.9 --max-
gap 500”. Intersection of peaks between the two replicates was
taken. Peaks that show reduced signals in meCLICK-Seq
compared to WT were selected as the final set.
To search for motifs, DNA sequences of peaks were
extracted from the GRCh38 genomic FASTA file. Motifs
were discovered by MEME-chip 5.0.550 using parameters
“-meme-nmotifs 30”. For gene quantification, exonic regions
were obtained from Ensembl GRCh38, version 93. Number of
reads in each exon was calculated by customized code and
normalized by RPKM. To counter the 3′ bias, the level of the
most 3′ exon was used as expression of the gene.
m6A sites were analyzed by first mapping Reads from the
miCLIP experiments to the GRCh38 assembly using STAR
2.7.1a45 with arguments “--outFilterMismatchNoverReadLmax
0.05 --alignIntronMax 0”. Forward and reverse genomic-
coverage tracks were subsequently produced by the bamCo-
verage function in deepTools 3.3.246 with arguments
“--normalizeUsing None --filterRNAstrand forward” and
“--normalizeUsing None --filterRNAstrand reverse” respec-
tively. Regions with nonzero coverage were extracted by
customized codes. Sites called from 4 miCLIP runs were
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Mechanisms for the Cleavage and Isomerization of the Phospho-
diester Bonds of RNA by Brønsted Acids and Bases. Chem. Rev. 1998,
98 (3), 961−990.
(23) Barbieri, I.; Tzelepis, K.; Pandolfini, L.; Shi, J.; Millań-
Zambrano, G.; Robson, S. C.; Aspris, D.; Migliori, V.; Bannister, A. J.;
Han, N.; De Braekeleer, E.; Ponstingl, H.; Hendrick, A.; Vakoc, C. R.;
Vassiliou, G. S.; Kouzarides, T. Promoter-bound METTL3 maintains
myeloid leukaemia by m6A-dependent translation control. Nature
2017, 552 (7683), 126−131.
(24) Vu, L. P.; Pickering, B. F.; Cheng, Y.; Zaccara, S.; Nguyen, D.;
Minuesa, G.; Chou, T.; Chow, A.; Saletore, Y.; MacKay, M.;
Schulman, J.; Famulare, C.; Patel, M.; Klimek, V. M.; Garrett-
Bakelman, F. E.; Melnick, A.; Carroll, M.; Mason, C. E.; Jaffrey, S. R.;
Kharas, M. G. The N6-methyladenosine m6A-forming enzyme
METTL3 controls myeloid differentiation of normal hematopoietic
and leukemia cells. Nat. Med. 2017, 23 (11), 1369−1376.
(25) Pendleton, K. E.; Chen, B.; Liu, K.; Hunter, O. V.; Xie, Y.; Tu,
B. P.; Conrad, N. K. The U6 snRNA m6A Methyltransferase
METTL16 Regulates SAM Synthetase Intron Retention. Cell 2017,
169 (5), 824−835.
(26) Bokar, J. A.; Shambaugh, M. E.; Polayes, D.; Matera, A. G.;
Rottman, F. M. Purification and cDNA cloning of the AdoMet-
binding subunit of the human mRNA (N6-adenosine)-methyltransfer-
ase. RNA 1997, 3 (11), 1233−1247.
(27) Wiederschain, D.; Wee, S.; Chen, L.; Loo, A.; Yang, G.; Huang,
A.; Chen, Y.; Caponigro, G.; Yao, Y.-M.; Lengauer, C.; Sellers, W. R.;
Benson, J. D. Single-vector inducible lentiviral RNAi system for
oncology target validation. Cell Cycle 2009, 8 (3), 498−504.
(28) Leger, A.; Amaral, P. P.; Pandolfini, L.; Capitanchik, C.;
Capraro, F.; Barbieri, I.; Migliori, V.; Luscombe, N. M.; Enright, A. J.;
Tzelepis, K.; Ule, J.; Fitzgerald, T.; Birney, E.; Leonardi, T.;
Kouzarides, T. RNA modifications detection by comparative Nano-
pore direct RNA sequencing. bioRxiv 2019, 843136, https://www.
biorxiv.org/content/10.1101/843136v1.
(29) Doxtader, K. A.; Wang, P.; Scarborough, A. M.; Seo, D.;
Conrad, N. K.; Nam, Y. Structural Basis for Regulation of METTL16,
an S-Adenosylmethionine Homeostasis Factor. Mol. Cell 2018, 71
(6), 1001−1011.
(30) Yang, D.; Qiao, J.; Wang, G.; Lan, Y.; Li, G.; Guo, X.; Xi, J.; Ye,
D.; Zhu, S.; Chen, W.; Jia, W.; Leng, Y.; Wan, X.; Kang, J. N6-
Methyladenosine modification of lincRNA 1281 is critically required
for mESC differentiation potential. Nucleic Acids Res. 2018, 46 (8),
3906−3920.
(31) Zhang, J.; Guo, S.; Piao, H.-Y.; Wang, Y.; Wu, Y.; Meng, X.-Y.;
Yang, D.; Zheng, Z.-C.; Zhao, Y. ALKBH5 promotes invasion and
metastasis of gastric cancer by decreasing methylation of the lncRNA
NEAT1. J. Physiol. Biochem. 2019, 75 (3), 379−389.
(32) Zhou, K. I.; Parisien, M.; Dai, Q.; Liu, N.; Diatchenko, L.;
Sachleben, J. R.; Pan, T. N6-Methyladenosine Modification in a Long
Noncoding RNA Hairpin Predisposes Its Conformation to Protein
Binding. J. Mol. Biol. 2016, 428, 822−833.
(33) Huang, H.; Weng, H.; Zhou, K.; Wu, T.; Zhao, B. S.; Sun, M.;
Chen, Z.; Deng, X.; Xiao, G.; Auer, F.; Klemm, L.; Wu, H.; Zuo, Z.;
Qin, X.; Dong, Y.; Zhou, Y.; Qin, H.; Tao, S.; Du, J.; Liu, J.; Lu, Z.;
Yin, H.; Mesquita, A.; Yuan, C. L.; Hu, Y.-C.; Sun, W.; Su, R.; Dong,
L.; Shen, C.; Li, C.; Qing, Y.; Jiang, X.; Wu, X.; Sun, M.; Guan, J.-L.;
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